Home
PFS & Injectable Drug Devices Europe
12 January - 14 January 2027
PFS & Injectable Drug Devices Europe

Conference Overview

FREE TO ATTEND FOR PHARMA AND BIOTECH


Kick off 2027 and set the tone for the year at 19th Annual PFS & Injectable Drug Devices Europe Conference!

Join us in London next January where we will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program.

Mark your calendar and be part of this must-attend event in January 2027. We look forward to welcoming you to London!
 

sponsors

Conference agenda

clock

8:00

Registration & Coffee

clock

8:50

Chair's Opening Remarks

clock

9:00

Developing Successful Combination Products: Integrating Science, Engineering and Human Factors from Concept to Commercialisation

  • Aligning drug, device and human factors teams early to define product requirements, development strategy and regulatory expectations
  • Understanding how formulation, dose volume, viscosity and delivery requirements influence device design, testing and validation throughout development
  • Applying a holistic combination product approach, incorporating scientific justification, measurement strategies, manufacturing considerations and ISO 11608 requirements to support successful product launch and lifecycle management
  • clock

    9:30

    Session Reserved for Sponsor

    clock

    10:00

    Why Regulatory Strategies Fail—and How to Win with Combination Product

  • Common strategy pitfalls
  • Align clinical, device, and CMC
  • Winning globally: FDA, EU, and beyond
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Article 117: Key Challenges, Updates and Lessons Learned

  •  Understanding evolving Notified Body expectations and recent regulatory guidance for Article 117 submissions
  • Addressing common challenges around data readiness, technical documentation, and GSPR compliance
  • Sharing practical strategies to streamline submissions, reduce delays, and improve approval predictability
  • clock

    11:30

    Session Reserved for Sponsor - Suttons Creek

    clock

    12:00

    Panel Discussion: Future of Drug Delivery: What’s Next in Drug Delivery and Device Design?

  •  Exploring next-generation delivery technologies beyond traditional PFS
  • Balancing innovation with cost, scalability, and real-world patient usability
  • Understanding how digital and material advancements will shape the future of device design
  • clock

    12:45

    Session Reserved for Sponsor

    clock

    13:15

    Networking Lunch

    clock

    14:15

    Improving Health Outcomes Through Patient-Centric Design: Expanding Beyond the Physiological – The BEAMER Approach

  • Expanding the focus from purely physiological needs to a broader understanding of patient behaviours, motivations, and real-world challenges to improve adherence and health system efficiency
  • Introducing the BEAMER / B-COMPASS model and how behavioural insights can be applied to design more effective, patient-centred solutions
  • Demonstrating how shifting to human-centric design approaches can drive improved treatment adherence, better patient outcomes, and overall healthcare value
  •  

    clock

    14:45

    Panel Discussion: Advancing Quality by Design and Design Controls in Device Development

  • How are organisations strengthening the link between QbD principles and design control processes?
  • Best practices for improving collaboration, risk management,and development efficiency across teams
  • Building a stronger foundation for innovation, regulatoryreadiness, and product quality in combination productdevelopment
  • clock

    15:15

    Afternoon Tea

    clock

    15:45

    Integration of Quality by Design (QbD) and design controls in device development

  •  Current State of the Industry: The BioPharma sector is advancing in its use of QbD and design controls, but maturity levels vary widely - highlighting gaps in how CQAs, control strategies, and design inputs are interconnected across organizations
  • Why Integration Is Important: Stronger integration between QbD principles and design control is essential to reduce development friction, enable clearer alignment across cross-functional teams, and create a more consistent foundation for device–drug combination product quality
  • Benefits of Integration: A unified framework and shared training can streamline development, enhance risk management, and improve regulatory readiness - ultimately accelerating innovation while supporting sustainability and robust product performance
  • clock

    15:45

    Platform-Based Drug Delivery Development – Opportunities, Challenges and Future Directions

  •  Sharing experiences and lessons learned from implementing platform-based device development strategies
  • Discussing how platform approaches can reduce development timelines, costs, and regulatory burden
  • Exploring the balance between standardisation, flexibility, and evolving patient and product requirements
  • clock

    15:45

    Building Effective Collaboration Across Combination Product Development

  • Integrating pharmaceutical sciences, device engineering sciences, manufacturing, regulatory and user perspectives to support informed cross-functional decision-making
  • Building effective collaboration models that translate patient and product requirements into successful combination product development and commercialisation strategies
  • Identifying opportunities to strengthen collaboration and decision making as combination products become increasingly complex, data-driven and globally regulated
  • clock

    15:45

    Utilising AI in Device Development – From Concept to Practical Application

  • Identifying where AI is already delivering value across design, testing, and manufacturing
  • Moving from experimentation to validated, regulatory-compliant use cases
  • Integrating AI into existing development workflows without increasing complexity
  • clock

    17:30

    Chair’s Closing Remarks and Close of Focus Day

    clock

    8:00

    Registration & Coffee

    clock

    8:50

    Chair's Opening Remarks

    clock

    9:00

    Building the Next Generation of Combination Products Through Platform Innovation

  • Applying platform-based thinking to streamline device development across multiple therapies
  • Enhancing collaboration between drug, device, and manufacturing teams throughout the product lifecycle
  • Overcoming technical and operational challenges when scaling device platforms for global markets
  • clock

    9:30

    Session Reserved for Gold Sponsor - MGS

    clock

    10:00

    Notified Body Opinions for a Legacy Products, How Hard Can They Be?

  •  Notified Body Opinions are now routine for new combination products, but are still relatively rare for legacy approved products.
  • What are the potential challenges and pitfalls associated with seeking a NBOp for a legacy approved product?
  • What best practices that may be applied to aid in a successful NBO process for a legacy product?
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Topic Heading 3

    clock

    11:30

    Session Reserved for Sponsor

    clock

    12:00

    Panel Discussion: Embedding Sustainability into Device Development

  •  Integrating sustainability into design, regulatory strategy, and human factors, what’s changing in practice
  • Balancing environmental goals with usability, patient outcomes, and commercial viability
  • Moving beyond siloed “green” initiatives to fully embedded, cross-functional development approaches
  • clock

    12:45

    Networking Lunch

    clock

    15:40

    Afternoon Tea

    clock

    14:00

    Chair's Opening Remarks

    clock

    14:10

    Human Factors and Usability Challenges in Large-Volume Injection Devices

  •  Addressing the unique usability challenges associated with high volume drug delivery
  • Applying human factors testing to optimise device design, instructions for use (IFUs), and labelling
  • Translating user insights into practical design solutions to support safe and effective product adoption
  • clock

    14:40

    Session Reserved for Nemera

    clock

    15:10

    Device Development Strategy in Early Drug Development

  • Device strategy must start early: Decisions on formulation, presentation, and delivery platform made before or during Phase 1 can significantly constrain future device options and commercialization pathways
  • Define a device selection point before Phase 1: Early alignment across formulation, device, clinical, and manufacturing teams reduces the risk of costly late-stage changes, additional studies, or reformulation
  • Integrated planning reduces risk: Proactively evaluating device constraints and using parallel cross-functional development improves predictability, accelerates development, and increases the likelihood of commercial success
  • clock

    16:10

    Driving Novel Device Development Through Platform Innovation

  • Applying platform approaches across pre-fi lled syringes, autoinjectors, and pen injectors to accelerate innovation
  • Balancing common device architectures with the need for differentiated patient experiences
  • Lessons learned from developing next-generation delivery systems across multiple product platforms
  • Navigating updates to ICH guidance for drug-device combination product content and understanding the impact on future regulatory submissions
  • clock

    16:40

    Session Reserved for Credence MedSystems

    clock

    17:10

    Session Reserved

    clock

    17:40

    Chair’s Closing Remarks and Close of Day One

    clock

    7:00

    Chair's Opening Remarks

    clock

    14:40

    Session Reserved for Haselmeier

    clock

    15:10

    Driving Sustainability in Drug Delivery Devices: From Ambition to Action

  •  Embedding circular economy principles into the development, manufacture, and end-of-life management of drug delivery devices
  • Balancing sustainability goals with patient needs, regulatory requirements, and product performance
  • Exploring opportunities for collaboration across the value chain to reduce environmental impact and accelerate progress
  • clock

    15:10

    Reducing Carbon Impact Across the Patient Care Pathway: Advancing Sustainable Drug Delivery Development

  •  Measuring and reducing product carbon footprints through lifecycle assessment (LCA) and data-driven decision making
  • Driving sustainability through material innovation, circularity initiatives, and responsible device design
  • Improving patient outcomes and reducing healthcare burden through at-home administration and next-generation drug delivery devices
  • clock

    15:40

    Afternoon Tea

    clock

    16:10

    Driving Sustainable Packaging Compliance: Preparing for the EU Packaging and Packaging Waste Regulation (PPWR)

  • Understanding the impact of PPWR on pharmaceutical packaging design, materials selection, and lifecycle management
  • Leveraging industry collaboration, baseline waste data, and shared toolkits to support effective compliance strategies
  • Balancing packaging reduction, product protection, and patient needs while meeting evolving sustainability requirements across Europe
  • clock

    16:40

    Session Reserved for DCA Design

    clock

    17:10

    EFPIA Perspective on Article 117: Lessons Learned and the Road Ahead

  •  Reviewing key challenges and successes from five years of Article 117 implementation
  • Exploring industry expectations for Notified Body opinions, timelines, and regulatory alignment
  • Identifying opportunities to improve predictability, collaboration, and lifecycle management for integral drug–device combination products including emerging risk-based approaches
  • clock

    17:40

    Chair's Closing Remarks and Close of Day One

    clock

    8:00

    Registration & Coffee

    clock

    8:50

    Chair's Opening Remarks

    clock

    9:00

    Bridging the Gap: Ensuring Lab-Based Device Verification Reflects Real-World Use in 2027

  • Identifying where traditional lab-based and automated testing still fail to capture real-world user variability, edge cases, and human-driven failure modes
  • Integrating human factors, risk management, and regulatory expectations into next-generation verification strategies to strengthen evidence packages
  • Leveraging advanced simulation, digital tools, and user-informed test design to generate robust, regulator-ready data demonstrating real-world performance
  • clock

    9:30

    Session Reserved for Gold Sponsor

    clock

    10:00

    Applying AI in Medical Device Development – Opportunities, Regulations, and Practical Lessons

  •  Where AI Creates Value in Design and Development
  • From Chatbots to Intelligent Systems: AI Deployment Models
  • Regulatory and Quality Expectations for AI in Regulated Environments
  • Lessons Learned from Early AI Adoption
  • The Future of AI in Device Development: Opportunities and Challenges
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Advancing Innovation in Injectable Device Development

  • Exploring key considerations for successful device
  • development across the product lifecycle
  • Balancing patient needs, usability, and technical
  • requirements in device design
  • Current and future priorities for Sandoz
  • clock

    11:30

    Session Reserved for Sponsor

    clock

    12:00

    Panel Discussion: AI in PFS & Injectable Drug Devices: From Concept to Patient Impact

  • Where AI is already making a difference in device design, manufacturing, and quality
  • Practical use cases for AI across the PFS lifecycle, and where the limits still are
  • Keeping innovation patient centric: improving usability, safety, and outcomes while adopting AI
  • clock

    12:45

    Networking Lunch

    clock

    14:00

    Chair's Opening Remarks

    clock

    14:10

    Combined Experimental and Computational Approach to Analyze Strain on Vials During Freezing

  • Frozen drug product storage can induce mechanical strain on glass vials, potentially causing vial breakage
  • A combined methodological approach – experimental strain gauge measurements and finite element analysis, was developed to systematically characterize strain formation during freezing
  • Key influencing factors (formulation composition, vial type, process parameters) were identified and effective strain-mitigating strategies derived
  • clock

    14:40

    Session Reserved for Gerresheimer

    clock

    15:10

    Next-Generation CCIT: Robust Helium Leak Testing via ICH Q14 Principles

  •  ICH Q14 Enhanced Validation Pathway: Establishes a comprehensive, deterministic validation pathway for quantitative helium leak detection by using multivariate Design of Experiments (DoE) to map a Method Operable Design Region (MODR)
  • Modular Microcapillary Positive Controls: Introduces highly adaptable, modular positive controls to systematically evaluate precision, specificity, and the limit of quantitation (LoQ)
  • Correction of Statistical Assumptions: Identifies distinct data heteroscedasticity across the test range, invalidating traditional homoscedastic Gage R&R models and establishing relative standard deviation (RSD) as the necessary metric for precision validity
  • clock

    15:40

    Afternoon Tea

    clock

    16:10

    Navigating Regulatory Change for PFS and Injectable Devices in the EU and UK

  • Key regulatory developments impacting combination products and device-led submissions
  • Interpreting evolving EU and UK requirements across the product lifecycle
  • Practical considerations for manufacturers during a period of regulatory transition
  • clock

    16:40

    Session Reserved for Sponsor

    clock

    17:10

    EDDOs for SDD/mPFS and Control Strategy

  • Identifying and defining critical device performance parameters for single-dose devices or manual pre-filled syringes
  • Linking elemental device design outputs to verification, risk management, and control strategy across development and manufacturing
  • Ensuring consistent product quality and performance through robust control
  • clock

    17:40

    Chair’s Closing Remarks and Close of Day Two

    clock

    14:00

    Chair's Opening Remarks

    clock

    14:10

    Human Factors as a Critical Strategic Asset: Leveraging prior Pre-filled Syringes Human Factors Data to accelerate Safe and Effective Drug Delivery

  • Leveraging Decades of Human Factors Knowledge by Understanding the Enduring Nature of Prefilled Syringe User Interactions
  • Moving Beyond Individual Studies: Leveraging Platform Human Factors Data and Use-Related Risk Knowledge from Established PFS Systems to Support Regulatory Confidence and Smarter Development Decisions
  • Building a Future-State Human Factors Strategy: Harnessing Historical PFS Data While Applying a Risk-Based Framework to Ensure Every New Drug-Device Combination Remains Safe, Effective, and Patient-Centric
  • clock

    14:40

    Session Reserved for Sponsor

    clock

    15:10

    Patient-Centric Device Development: Designing Drug Delivery Solutions Around Real Patient Needs

  •  Understanding patient needs and translating user insights into device and packaging design decisions
  • Improving usability, adherence, and accessibility through human-centred development approaches
  • Lessons learned from developing patient-friendly injectable devices and packaging solutions across diverse patient populations
  • clock

    15:40

    Afternoon Tea

    clock

    16:10

    Validating Patient Behaviour Insights to Improve Adherence Outcomes

  • Technical deep dive into the BEAMER behavioural model and segmentation of patient groups based on needs and adherence drivers
  • Results from EU and global pilot studies, including validation of adherence prediction and targeted support approaches
  • Designing patient-centric solutions to improve usability, outcomes, and value in healthcare systems
  • clock

    16:40

    Session Reserved for Sponsor

    clock

    17:10

    Utilisation of Digital Endpoints in Injectable Drug Device Development

  •  How digital endpoints and connected device data can generate objective insights into patient adherence, treatment outcomes, and device performance
  • Integrating digital endpoint strategies into device development programmes to support evidence generation and patient-centric product design
  • clock

    17:40

    Chair’s Closing Remarks and Close of Day Two

    Confirmed Speakers Include:

    Gold Sponsors

    Silver Sponsors

    Exhibitors

    Official Media Partner

    Supporters

    VENUE

    Marriott Hotel Grosvenor Square

    Grosvenor Square, London, London, United Kingdom

    ">

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing SMi Group Trading As SAE Media Group. SMi Group Trading As SAE Media Group books all hotel rooms directly. If you are approached by a third-party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third-party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Editor’s Corner

    Stay informed on the latest developments in pre-filled syringes, combination devices and injectable drug devices. Gain the latest in-depth news on real-time developments in the industry straight to your inbox each month to stay ahead.
    If your organization would like to submit any news stories and press releases to be covered, please send them through to PFSnewsletter@saemediagroup.com for consideration.
    Subscribe here

    Sponsors and Exhibitors


    MGS

    Gold Sponsors
    http://mgsmfg.com

    A global provider of healthcare contract development and manufacturing solutions, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities combined with the strong customer focus and seamless collaboration of an agile partner. That’s why we’re the healthcare CDMO of choice for today’s leading Pharma, Diagnostic and MedTech companies.



    SHL Medical

    Gold Sponsors
    http://www.shl-medical.com

    SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions that enhance patients’ treatment experience and quality of life. Our customers benefit from our proven track record and scalable, global manufacturing excellence, with locations across three continents and headquarters in Switzerland. By focusing on innovation, we challenge the status quo and shape the future of state-of-the-art drug delivery. We cover the entire drug delivery value chain, providing peace of mind through our end-to-end services, from design, development, to final assembly, labeling, and packaging.

    Sponsors and Exhibitors


    Credence MedSystems

    Silver Sponsors
    http://www.credencemed.com

    Credence MedSystems is an innovator in injectable drug delivery devices. Credence’s philosophy of Innovation Without Change results in products that impress and protect end-users while preserving pharma’s existing processes, sourcing strategies and preferred primary package components. The Companion® family of syringe systems includes proprietary needle-retraction technology, reuse prevention and other critical safety and usability features in Staked and Luer needle formats. The Dual Chamber platform offers single-step mixing and injection for drugs requiring reconstitution at the time of delivery. Additional products such as metered dose devices, multi-length staked needles and other novel devices address the needs of specific therapeutic markets.


    DCA

    Silver Sponsors
    https://www.dca-design.com/

    DCA offer comprehensive design, development and analysis solutions for the medical devices industry.

    Our multidisciplinary team offers an integrated, evidence based service focused on helping our clients achieve success through great product design.

    With a wealth of experience in developing leading injection devices for global markets, DCA’s work includes: variable dose pen injectors, single and multi-fixed dose injectors, disposable and reusable products, autoinjectors, wearable patch injectors, large volume injectors, connected and electro-mechanical devices.

    Our portfolio encompasses mass-market injectors that are manufactured in multi-billions, as well as lower volume devices targeting specific user populations and regional market needs. Alongside device design, we provide comprehensive support for industrialisation/production and create innovative instructions and product packaging solutions.

    Since 2000 our team have created over 1,700 granted patents for our clients. In the last 10 years we have received over 100 major design awards and supported our clients to launch more than 100 new products. We can provide expert support for device strategy, usability, due diligence, connectivity, mechanical engineering, electronics, medical device software, industrial design, UX/UI development, prototyping, industrialisation/production support, packaging and instruction design. We are certified to ISO13485 and work to ISO14971, IEC62304 and IEC62366.



    Gerresheimer

    Silver Sponsors
    http://www.gerresheimer.com

    Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical primary packaging, drug delivery systems and digital solutions. Gerresheimer ensures that medicines reach patients safely and can be administered reliably. With around 12,000 employees and 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets with a focus on the pharma industry.



    Haselmeier

    Silver Sponsors
    https://haselmeier.com/en/

    o Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems such as pen injection systems and autoinjectors. Patient comfort and customers’ needs are always at the heart of the company’s practices. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self-administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record in providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. Medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. With more than 100 years of expertise in the development and manufacture of drug delivery devices, our global footprint, nearly 250 distinguished and motivated experts, more than 200 patents granted, and numerous patents pending, Haselmeier remains committed to developing innovative solutions that support our customers and help improve the health of millions of people worldwide.



    Nemera

    Silver Sponsors
    http://www.nemera.net

    As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.



    Suttons Creek

    Silver Sponsors
    http://www.suttonscreek.com

    Suttons Creek is pharma’s device team. Any company adopting combination product technology needs an experienced combination products team working alongside their drug team, including specialists in areas like quality, regulatory, vendor selection and management, systems engineering, risk management, clinical development, and commercialization. Suttons Creek has over 650 years of combined experience and 120+ combination product projects under its belt, with a talent pool of subject matter experts that specialize in all aspects of combination product development from strategic planning through device development to launch and postmarket activities. We can be any or all things combination product to a client, consulting hour by hour or engaging in strategic partnerships to achieve milestones, lift roadblocks, fill knowledge gaps, and drive program success.


    Exhibitors


    Harro Höfliger

    Exhibitors
    http://www.hoefliger.com

    Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.

    The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.



    Kern Liebers

    Exhibitors
    https://www.kern-liebers.com/en

    KERN LIEBERS, a medium-sized family company based in southwest Germany, is a global technology leader for the engineering and production of highly complex metal components and hybrid assemblies at over 40 locations around the world. Specialized in tailor made SMART SPRINGS and SMART PARTS for specific drug delivery systems.

    SMART SPRINGS - Customized Intelligent Power Packs Design elements as trigger mechanism for drug administration and energy storage in drug delivery systems. Global manufacturer and engineering partner of wire springs, wave springs and flat springs.

    SMART PARTS – Customized, Highly Complex Components Design elements for all kind of safety-relevant functions. Global manufacturer and engineering partner of stamped-bent parts, micro-stamped components, assemblies and laser welded parts.

    Billions of safety-relevant metal components have been manufactured since the 19th century at KERN LIEBERS. The function of these structural elements ensures the highest level of protection for human life with an upward trend. There are many parallels of safety-relevant parts with regard to highest requirement of reliability and an absolute mode of functionability in all industries, especially in the medical industry. KERN LIEBERS proves this time and again through perfectly customized engineering solutions together with the customer, manufacturing expertise and an awareness of individual, visionary solutions.



    Kindeva

    Exhibitors
    https://www.kindevadd.com/about-us/

    As a purpose-fueled drug delivery CDMO, we leverage our specialist injectable, inhalation and dermal expertise to accelerate your product’s journey and make tomorrow’s possibilities a reality.

    From development to commercial manufacturing and beyond, amplify your product’s impact with our exceptional-by-design CDMO solutions.

    Our Bridgeton facility has over 155,000 sq. ft. of dedicated aseptic operations space, including state-of-the-art laboratories and formulation suites, alongside almost 11,000 sq. ft. of fill suites to ensure the highest levels of quality and patient safety.

    Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.



    Owen Mumford

    Exhibitors
    http://www.ompharmaservices.com

    Owen Mumford Pharmaceutical Services is a specialist in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech & generics industries. These include single dose and multidose reusable and disposable auto-injectors, pens and syringes for subcutaneous and intramuscular administration. Our innovative products are designed to meet both the need of our pharmaceutical partners and their patients by facilitating ease of use and improving safety and patient compliance. Our devices are also designed with aim of reducing complexity and risk for the pharmaceutical & biotech industry in the development of their combination products.


    PCE Automation

    Exhibitors
    https://pceautomation.co.uk/en_gb/

    PCE Automation is a specialist automation company serving the Life Sciences industry. Family-run and built on a foundation of hands-on engineering expertise, we design and deliver automation solutions tailored to the exacting standards of pharmaceutical, medical device, and diagnostics manufacturers. With three sites operating globally, we combine local responsiveness with the scale and consistency our clients need to bring critical products to market reliably and efficiently. As a business, we bring a personal, long-term approach to every partnership — treating our clients' challenges as our own.


    Smithers

    Exhibitors
    https://www.smithers.com/en-gb/home

    Smithers Medical Device Testing supports medical device and pharmaceutical manufacturers in bringing innovative, compliant, and high-performing products to market through expert, independent testing services. Operating from accredited laboratories in the USA, UK, and Europe, Smithers offers a comprehensive range of services including extractables and leachables (E&L) studies, functional testing for medical and combination devices, packaging validation, and advanced materials testing. With deep technical expertise and a commitment to the highest quality standards, Smithers partners with clients at every stage of the product lifecycle—from early R&D through regulatory submission and beyond—to ensure performance, efficacy, and global market readiness.



    Terumo

    Exhibitors
    https://www.terumopharmaceuticalsolutions.com/en-EMEA

    As Part of Terumo Medical Care Solutions, the Pharmaceutical Solutions Division develops patient-oriented parenteral delivery solutions for therapeutic performance and safety.

    Globally trusted for quality and precision, we offer pharmaceutical and medical device manufacturers around the world comprehensive product design and development services.

    We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery.

    Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies, including CDMO services for all parenteral applications.

    We listen. We question. We deliver.


    Media Partners


    OnDrugDelivery

    Official Media Partner
    https://ondrugdelivery.com/subscribe/

    ONdrugDelivery is the topic-specific b2b drug delivery publication that focuses from cover-to-cover on one topic area within the field of drug delivery with each issue. Pharma’s go-to source for drug delivery industry information since 2005, ONdrugDelivery’s content is available in free digital and paid print formats. Subscribe today! https://www.ondrugdelivery.com/subscribe

    Media Partners


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    IPI

    Supporters
    https://international-pharma.com/

    IPI – International Pharmaceutical Industry Established by professionals with over 30 years experience in the Pharmaceutical and Life sciences publishing sectors. We have identified the needs of these dynamic industries, and have listened carefully to our readers and advertisers. With strong collaboration between Pharmaceutical and Life sciences Industry Associations we have created a global distribution network. We give you a promise to become a reliable extension of your marketing and communication arm. If necessary we will integrate our expertise with your needs. Incorporating new and innovative communication methods we will help to highlight your expertise.


    Drug Development & Delivery

    Supporters
    http://www.drug-dev.com

    Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals.


    Medical Design Briefs

    Supporters
    http://WWW.TECHBRIEFS.COM/SUBSCRIBE/MDB/SMIEAST21

    Medical Design Briefs (MDB) is the only publication for the medical OEM market dedicated to medical product design engineers and managers. We offer timely, accurate, quality content and editorial, and we report on engineering-related topics that are at the core of the latest medical technologies. From materials to manufacturing, we dive into the technical side of bringing medical devices to market. From biosensors to cybersecurity, we keep our fingers on the pulse of the hottest trends and topics that may augment or disrupt medical technology.


    IBI - International Biopharmaceutical Industry

    Supporters
    https://international-biopharma.com/

    IBI - International Biopharmaceutical Industry, provides the biopharmaceutical industry with comprehensive coverage of key scientific, technology, regulatory and business topics. The editorial mix of peer-reviewed papers, practical advice on managing bioprocessing and technology, regulatory and business columns, and expert commentary provides comprehensive coverage of upstream and downstream processing, manufacturing operations, regulations, formulation, scale-up/technology transfer, drug delivery, analytical testing and more. The insight and analysis covers biologic – based therapies including We will report on emerging trends, strategies and best practices in the key areas.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    Marriott Hotel Grosvenor Square

    Grosvenor Square
    London W1K 6JP
    United Kingdom

    Marriott Hotel Grosvenor Square
    " frameborder="0">

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content

    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group


    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.

    Join the Loitering Munitions community

    Keep up to date with industry news, insights, and community updates FREE and direct to your inbox every month!
    * - required fields
    You can unsubscribe at any time. For full details see our Privacy Policy

    Download the 2026 Defence Events Calendar here to view the full list of SAE Media Group’s conferences this year

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.